Doctor discusses treatment options for the Omicron variant – archyde

LOUISVILLE, Kentucky (WAVE) – Doctors continue to learn more about the Omicron variant, including how to treat it.

Dr. Valerie Briones-Pryor of the University of Louisville Health said getting help early is key.

“The most important thing I tell people is if you feel sick and it just doesn’t get better, please seek help,” she pleaded.

As of Thursday, UofL Health has 113 COVID-positive patients, 25 of whom are in the intensive care unit, 12 of whom are ventilated. Dr. Briones-Pryor said about 89 percent of these patients were unvaccinated.

She said the problem is that many people wait too long before seeking help.

“You are young, you are healthy, and I understand you want to wait and see. But then a week goes by, two weeks go by and the problem with COVID is that some people have that period where they actually get worse a week after their symptoms started, “she explained.

Dr. Briones-Pryor said one treatment that needs to be done early is treatment with monoclonal antibodies.

She said early data suggests the current treatment for Omicron may not be as effective, but it’s worth trying.

“We’ll try anyway, if you’re a candidate, hoping it’ll work,” said Briones-Pryor. She said a newer version of the monoclonal antibody treatment is being used, which is expected to fight Omicron better than previous versions.

Dr. Briones Pryor said UofL Health is still awaiting shipments of it, along with two COVID treatment pills that have been FDA cleared for emergency use.

“I think it will be great to have another weapon in our arsenal against COVID,” she said. “It’s not a cure, but there is other treatment out there and available so people don’t get too sick and end up in the hospital to see me.”

Dr. Briones Pryor said Omicron appears to be mild in people who have been vaccinated. Individuals treating it at home should take vitamins, antipyretic drugs, and drink plenty of water.

Copyright 2021 WAVE 3 news. All rights reserved.

Reference-www.nach-welt.com

Leave a Reply

Your email address will not be published. Required fields are marked *